Mutual Funds & ETF's
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
FDA Approves Santarus' UCERIS for Induction of Remission in Patients with Active, Mild to Moderate Ulcerative Colitis
Latest Articles from Benzinga.com
Posted on January 14, 2013 at 20:17 PM EST
Santarus (NASDAQ: SNTS ) announced today that the U.S. Food and Drug Administration (FDA) has approved UCERIS™ (budesonide) extended release tablets for the induction of remission in patients with
Read More >>
GBL INV HSE
NewStar Financial, Inc.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here